NutriStack
Insulin Glargine and Magnesium Glycinate, a synergy.
Magnesium is a cofactor for insulin signaling, and low intracellular magnesium contributes to insulin resistance. Meta-analyses of oral magnesium supplementation in type 2 diabetes show modest reductions in fasting glucose, HbA1c, and HOMA-IR. Combined with insulin glargine, magnesium can improve insulin sensitivity over weeks and may modestly reduce basal insulin requirements without driving acute hypoglycemia.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Insulin Glargine and Magnesium Glycinate
- Pair type
- Synergy
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- +2 to your Stack Score (per scored synergy row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Synergy · Moderate evidence
Synergy
What is happening. Magnesium is a cofactor for insulin signaling, and low intracellular magnesium contributes to insulin resistance. Meta-analyses of oral magnesium supplementation in type 2 diabetes show modest reductions in fasting glucose, HbA1c, and HOMA-IR. Combined with insulin glargine, magnesium can improve insulin sensitivity over weeks and may modestly reduce basal insulin requirements without driving acute hypoglycemia.
Mechanism. Magnesium is required for autophosphorylation of the insulin receptor tyrosine kinase and for downstream signaling that drives GLUT4 translocation. Repleting magnesium improves cellular insulin sensitivity. Insulin glargine provides 24-hour basal insulin receptor activation. Improved sensitivity gradually reduces basal insulin needs.
Recommendation. If you take insulin glargine and your dietary magnesium is low, supplementation (typically 200-350 mg elemental magnesium/day) is reasonable. Monitor fasting glucose; if you notice persistent lows over weeks, ask your prescriber whether your glargine dose should be reduced.
Sources (2)
- Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26(4):1147-1152. PMID 12663588
- Asbaghi O, Moradi S, Kashkooli S, et al. The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr. 2022;128(12):2363-2372. PMID 35045911
Stack Score
How this pair moves the number.
Effect on the composite score
If both Insulin Glargine and Magnesium Glycinate are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.